Search results for

Steve Inskeep talks to Neil MacFarquhar of the New York Times about the bombing in Damascus on Wednesday that reportedly killed the Syrian defense minister and other officials.

Keynote speakers and vice presidential nominees give separate addresses. So unless tradition is going to be broken, choosing the New Jersey governor to deliver the keynote address at the GOP convention means he's not going to be on the ticket.

At least four people were killed and more than two dozen wounded at the airport in Burgas. There was an explosion on a bus that had just been boarded by Israelis who had arrived in the Baltic Sea resort.

YouTube said the tool was a first step toward providing anonymity in video.

The UK artist known as My Dog Sighs makes striking "can people" out of old food cans he finds and the cans people collect for him, then he leaves them on the street for others to find. But P.S: Don't tell anyone that he doesn't have a dog.

As many cities add bus and bike lanes, raise parking rates and increase traffic enforcement with cameras, some motorists feel like they're under attack. But advocates of these changes say they give people more options for getting around and make cities safer.

The drought that's impacting much the country is drying up crops and now rivers. The Mississippi River is experiencing water levels low enough to affect barge traffic. Barge companies are lightening loads, meaning more boats are needed for the same amount of cargo. Robert Siegel speaks with Mark Mestemacher, co-owner of Ceres Barge Line in St. Louis.

The 2008 GOP presidential nominee came to the defense of Hilary Clinton's longtime aide on the Senate floor. While Sen. John McCain didn't mention Rep. Michele Bachmann by name, he made clear he wants her to stop suggesting the aide is helping the Muslim Brotherhood.

After Timothy Ray Brown became the first person to be cured of HIV, scientists became more optimistic that they could find other ways to cure patients. Two of the most promising possibilities include a vaccine and gene therapy that would re-engineer the immune system.

It's been reported that the CEO and his management team stand to make millions if they stall the merger long enough.